Join to View Full Profile
504 E 63rd StAp 6oNew York, NY 10065
Phone+1 929-262-9067
Are you Dr. Munhoz?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 1 invite waiting! - Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Rodrigo Munhoz, MD is a hematologist in New York, New York.
Clinical Trials
- Nivolumab in Patients With Advanced Cutaneous Squamous Cell Carcinoma Start of enrollment: 2019 Sep 05
Publications & Presentations
PubMed
- Challenges of Treating Merkel Cell Carcinoma in Brazil.Matheus de Melo Lobo, João Pedreira Duprat Neto, Milton José de Barros E Silva, Rodrigo Ramella Munhoz, Andreia Cristina de Melo
Journal of Surgical Oncology. 2025-01-26 - Assessment of Rare Cancers and Sarcoma Policy and Sarcoma Drug Approvals in Latin America: A Report From the LACOG Sarcoma Group.Douglas Dias E Silva, Bruna Bianca Lopes David, Veridiana Pires de Camargo, Renee Zon Filipi, María Lucila González Donna
JCO Global Oncology. 2025-01-01 - 1 citationsEmerging Indications for Neoadjuvant Systemic Therapies in Cutaneous Malignancies.Domingos Sávio do Rego Lins Junior, Beatriz Mendes Awni Cidale, Ana Zelia Leal Pereira, Jacqueline Nunes de Menezes, Eduardo Bertolli
Medical Sciences. 2024-07-23
Press Mentions
Nivolumab Promising for Treatment of Advanced Cutaneous SCCOctober 26th, 2022- Promising Immunotherapy Drug May Soon Become Standard Treatment for Skin CancerOctober 26th, 2022
- Nearly Half of Parents Say They Have Leftover Prescription Medications at HomeOctober 24th, 2022
- Join now to see all
